WallStreetZen

NYSE: PFE
Pfizer Inc Earnings & Revenue

PFE past earnings growth

How has PFE's earnings growth performed historically?
Company
-7.45%
Industry
20.42%
Market
103.11%
PFE's earnings have grown slower (15.26% per year) than the US Drug Manufacturers - General industry average (16.62%)
Performance
PFE's earnings have grown slower (15.26% per year) than the US market average (30.14%)
Performance
PFE's earnings growth is slowing down - its growth over the last year (-7.45%) is below its 5-year compound annual rate (15.26%)
Performance

PFE past revenue growth

How has PFE's revenue growth performed historically?
Company
48.65%
Industry
18.46%
Market
45.4%
PFE's revenue has grown slower (-0.25% per year) than the US Drug Manufacturers - General industry average (5.44%)
Performance
PFE's revenue has grown slower (-0.25% per year) than the US market average (19.13%)
Performance
PFE's revenue growth is accelerating - its growth over the last year (48.65%) is above its 5-year compound annual rate (-0.25%)
Performance

PFE earnings and revenue history

Current Revenue
$51.6B
Current Earnings
$13.2B
Current Profit Margin
25.6%
PFE's has demonstrated consistent long-term earnings growth over the past 10 years (118.52%)
Performance

PFE Return on equity

Current Company
19.8%
Current Industry
33.2%
Current Market
32.9%
PFE's Return on Equity (19.8%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

PFE Return on assets

Current Company
8%
Current Industry
7.3%
Current Market
7.7%
PFE is generating higher Return on Assets (8%) than the US Drug Manufacturers - General industry average (7.53%)
Performance

PFE Return on capital employed

Current Company
10.84%
Current Industry
11.7%
PFE has gotten more efficient at generating Return on Capital (10.84%) compared to 3 years ago (9.89%)
Performance

PFE earnings dates

Next earnings date
Oct 25, 2021

Pfizer Earnings & Revenue FAQ

What were PFE's earnings last quarter?

On Invalid Date, Pfizer (NYSE: PFE) reported Q2 2021 earnings per share (EPS) of $0.99, up 57.14% year over year. Total Pfizer earnings for the quarter were $5.56 billion. In the same quarter last year, Pfizer's earnings per share (EPS) was $0.63.

What was PFE's earnings growth in the past year?

As of Q3 2021, Pfizer's earnings has grown -7.45% year over year. This is 27.87 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 20.42%. Pfizer's earnings in the past year totalled $13.23 billion.

What is PFE's earnings date?

Pfizer's earnings date is Invalid Date. Add PFE to your watchlist to be reminded of PFE's next earnings announcement.

What was PFE's revenue last quarter?

On Invalid Date, Pfizer (NYSE: PFE) reported Q2 2021 revenue of $18.98 billion up 92.39% year over year. In the same quarter last year, Pfizer's revenue was $9.86 billion.

What was PFE's revenue growth in the past year?

As of Q3 2021, Pfizer's revenue has grown 48.65% year over year. This is 30.19 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of 18.46%. Pfizer's revenue in the past year totalled $51.64 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.